BioPharm Reports (VennBio Ltd.), Jan 2011, Pages: 195
Biomarkers in BreastCancer - 2011 This report provides a comprehensive and up-to-date review of breastcancerbiomarkers. Recent years have seen the discovery of significant numbers of new
VDM Publishing House, Oct 2010, Pages: 172
STUDY OF SOME BIOMARKERS OF CANCERBREAST. Edition No. 1 Biochemical markers in oncology are molecules that can be detected in higher or lower than normal amounts in the blood, urine, or body tissues
Jain PharmaBiotech, May 2012, Pages: 873
of bone and soft tissue tumors
Biomarkers of Ewing’s tumors
Role of biomarkers in the diagnosis of bone tumors
Breastcancerbiomarkers
Autoantibody biomarkers of breastcancerBiomarkers of breast
GBI Research, Sep 2010, Pages: 78
($bn), 2007–2016
This growth is primarily attributed to the rise in the number of biomarker tests in the cancer types such as cervical cancer, NSCLC (non-small cell lung cancer), breastcancer, gastric
GBI Research, Oct 2011, Pages: 103
biomarkers market is an established one and forms an important part of the global biomarkers market. Within the tumor marker market, breastcancer is the highest earning due to the high prevalence rate
Business Insights, April 2008, Pages: 265
Targeted therapies and companion diagnostics
Tests based on DNA biomarkers
Tests based on RNA biomarkers
Tests based on protein biomarkersBiomarkers in breastcancer
Susceptibility
Detection
Prognosis
CurrentPartnering, May 2012, Pages: 250
BreastCancer Partnering 2007-2012 The BreastCancer Partnering 2007-2012 provides understanding and access to the breastcancer partnering deals and agreements entered into by the worlds leading
Datamonitor, July 2011, Pages: 36
trial design – patient selection, duration, clinical endpoints, and future developments in trial design
- The future of breastcancer treatment – increasing use of biomarkers, new combination therapies
Decision Resources, Inc., May 2010, Pages: 25
drug development: HER2, KRAS, EGFR, and BRAF; innovative ways to rethink validation of biomarker data: The Cancer Genome Atlas for gene expression and Genetic Alliance for rare diseases; drug trials
Future Medicine Ltd, Aug 2010, Pages: 92
breastcancerbiomarkers, gene-expression profiling in head and neck cancer, gene mutation in colorectal and non-small cell lung cancer, and epigenetic aberrations. EDITORIAL:
- Today’s discoveries
Select Biosciences Ltd, Oct 2011, Pages: 139
MicroRNA Associations with Physiological Situations and Various Disease Processes
- Cancer
- Hematological Cancers, Solid Tumors
- Cancer Personalized Medicine
- BreastCancer
- Lung Cancer
- Prostate
Jain PharmaBiotech, May 2012, Pages: 638
strategies vary according to the type and location of cancer. Role of drug delivery in the management of cancers of the brain, the bladder, the breast, the ovaries and the prostate are used as examples
Global Industry Analysts, Inc., Aug 2011, Pages: 1305
and Pipeline Biomarkers in Various Cancers 44
BreastCancer Dominates CancerBiomarkers Pipeline 44
Table 11: Global CancerBiomarkers Pipeline by Indication
(2010): Percentage Share Breakdown for Breast
Business Insights, Jan 2011, Pages: 130
, biomarkers and imaging methods have been applied to challenges of diagnosis in breastcancer and Alzheimer’s disease.
- Discover how centres of expertise, such as academic departments, are driving new
Business Insights, July 2010, Pages: 198
applications of imaging biomarkers
Summary
Introduction
Imaging biomarkers in clinical practice: oncology
Breastcancer screening with mammography
Established imaging biomarkers for oncology
Molecular
Decision Resources, Inc., April 2007, Pages: 34
- Trends in CancerBiomarker Development: Biomarker discovery and validation, as well as the role of the diagnostics.
- Emerging Biomarkers in Select Cancers: Bladder, breast, colorectal, lung, pancreatic
Jain PharmaBiotech, May 2012, Pages: 225
cytogenetics and biomarkers of genetic disorders as well as cancer. Biomarkers are very important for molecular diagnostics. Not only are molecular diagnostic technologies used for discovery of biomarkers
